Natera’s Signatera Test Integrated into Phase III Bladder Cancer Trial
The ARCHER study will evaluate shortened radiation therapy while using ctDNA testing to monitor treatment response and disease recurrence.
Category: Molecular Diagnostic Analyzers
Molecular Diagnostic Analyzers
Latest
Molecular Diagnostic Analyzers
Latest
Sepsis Test Shows the Value of Rapid Diagnosis  Â
Two case studies illustrate how a newly developed sepsis test improves turnaround times and diagnostic accuracy.
Molecular Diagnostic Analyzers
Latest
QIAGEN Upgrades its Syndromic Testing Analyzer
The QIAstat-Dx Analyzer 2.0 enables mobile access to test results, streamlining diagnostic processes and enhancing patient care.
PathogenDx Expands Reach of Multiplexed Molecular Testing Tech
PathogenDx expanded the reach of its patented multiplexed molecular testing technology, Dynamic Dimensional Detection (D3 Array).
Read More
Planned Parenthood Expands Access to STI Testing
Planned Parenthood Mar Monte (PPMM) has teamed with BD to provide STI testing for the most common infections to underserved populations.
Read More
The Opportunity to Upgrade Pharyngitis Testing
Pharyngitis testing and diagnosis can be improved by utilizing existing molecular testing capacity increased due to COVID.
Read More
As CML Outcomes Improve, Demand Rises for BCR::ABL1 Testing
Patients with chronic myeloid leukemia need regular BCR::ABL1 testing for the rest of their lives, which can translate into more lab work.
Read More
New Method for the Detection of RNA Viruses
Experts have developed a new methodology to detect RNA viruses based on the triplex-forming probe technology.
Read More
Using Electrochemical Cell-Free Biosensors for Antibody Detection
A new method of rapid, yet quantitative and specific point-of-care detection of antibodies uses an electrochemical cell-free biosensor.
Read More
COVID-19 Pandemic Pivot Shows the Benefits of Microarray Technology
PathogenDx’s involvement with Operation Warp Speed, demonstrated the efficacy of microarray technology for diagnostic testing.
Read More
DNA Testing Could Unlock Cancer’s Ancestral Roots
Researchers are revealing connections between cancer and race or ethnicity with software that infers ancestral roots in tumor DNA and RNA.
Read More
Bacterial Vaginosis & Trichomoniasis: Test-and-Treat as a Critical Component in Diagnosis
Bacterial vaginosis and trichomoniasis results in a range of health complications. A test-and-treat approach can improve diagnosis.
Read More
Llusern Debuts UTI Molecular Diagnostic Platform
UK diagnostics manufacturer, Llusern Scientific, will preview its Lodestar DX molecular diagnostic platform at the upcoming Medica 2022.
Read More
Exome Sequencing May Have Utility for Diagnosing Autism
Research underscores the positive outcomes of exome sequencing for individuals with ASD, supporting its use to reach a faster diagnosis.
Read More
Genetic Testing Helps Spot Children Likely to Have Heart Failure
Genetic testing can diagnose cardiomyopathy in children and help detect who will have heart failure and require a transplant.
Read More
Cue Applies for EUA for Flu + COVID-19 Molecular Test
Cue Health has announced that it submitted an application with the FDA for EUA for its Cue Flu + COVID-19 Molecular Test.
Read More
Cost-Effective Approach to Early Detection of Cancer Tested
UCLA researchers have found a cost-effective way for early detection of cancer using cell-free DNA in blood samples.
Read More
Who Should Be the Industry Watchmen?
Theranos whistleblower Tyler Shultz sees what he did as an in-case-of-emergency break glass option. But who should be the industry watchmen?
Read More